# Biomedical Research: Resources

## Government Data and Reports

### NIH Data and Tools

- **NIH RePORTER**: Searchable database of all NIH-funded research projects. <https://reporter.nih.gov/>
- **NIH Data Book**: Annual statistics on funding, applications, success rates, and workforce demographics. <https://report.nih.gov/nihdatabook/>
- **NIH Open Mike (blog)**: Commentary from NIH leadership on funding trends, policy changes, and extramural research data. <https://nexus.od.nih.gov/all/category/blog/>
- **NIH Grants and Funding**: Information on grant mechanisms, application process, and policies. <https://grants.nih.gov/>
- **ClinicalTrials.gov**: Registry and results database for clinical studies worldwide. <https://clinicaltrials.gov/>
- **iCite**: NIH tool for analyzing the influence and translation of research publications. <https://icite.od.nih.gov/>

### Other Federal Sources

- **Government Accountability Office (GAO)**: Reports on NIH management, efficiency, and outcomes. <https://www.gao.gov/>
- **Congressional Research Service (CRS)**: Policy analysis on NIH funding, biomedical workforce, and research policy. Available through member offices and some public repositories.
- **National Science Board**: *Science and Engineering Indicators*, biennial report on the state of U.S. research. <https://ncses.nsf.gov/indicators>
- **FDA**: Guidance documents on clinical trial design, drug approval pathways, and real-world evidence. <https://www.fda.gov/regulatory-information/search-fda-guidance-documents>

## National Academies Reports

- National Academies of Sciences, Engineering, and Medicine. *The Next Generation of Biomedical and Behavioral Sciences Researchers: Breaking Through*. Washington: National Academies Press, 2018.
- National Academies of Sciences, Engineering, and Medicine. *Reproducibility and Replicability in Science*. Washington: National Academies Press, 2019.
- National Academies of Sciences, Engineering, and Medicine. *The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation*. Washington: National Academies Press, 2012.
- Institute of Medicine. *Transforming Clinical Research in the United States: Challenges and Opportunities*. Washington: National Academies Press, 2010.
- National Academies of Sciences, Engineering, and Medicine. *Advancing Antibiotic Resistance Science: Implications for Research, Development, and Patient Access*. Washington: National Academies Press, 2022.

## Academic Research and Commentary

### Funding and Structure

- Alberts, Bruce, Marc W. Kirschner, Shirley Tilghman, and Harold Varmus. "Rescuing US Biomedical Research from Its Systemic Flaws." *Proceedings of the National Academy of Sciences* 111, no. 16 (2014): 5773-5777.
- Stephan, Paula. *How Economics Shapes Science*. Cambridge: Harvard University Press, 2012.
- Wahls, Wayne P. "The NIH Must Reduce Its Funding Concentration Index." *eLife* 7 (2018): e35498.
- Lauer, Michael S., et al. "Trends in the Age of Principal Investigators Supported by the National Institutes of Health." NIH Office of Extramural Research analysis, updated annually.
- Fang, Ferric C., and Arturo Casadevall. "NIH Peer Review Percentile Scores Are Poorly Predictive of Grant Productivity." *eLife* 5 (2016): e13323.

### Reproducibility and Rigor

- Begley, C. Glenn, and Lee M. Ellis. "Raise Standards for Preclinical Cancer Research." *Nature* 483 (2012): 531-533.
- Freedman, Leonard P., Iain M. Cockburn, and Timothy S. Simcoe. "The Economics of Reproducibility in Preclinical Research." *PLOS Biology* 13, no. 6 (2015): e1002165.
- Ioannidis, John P. A. "Why Most Published Research Findings Are False." *PLOS Medicine* 2, no. 8 (2005): e124.
- Open Science Collaboration. "Estimating the Reproducibility of Psychological Science." *Science* 349, no. 6251 (2015): aac4716.
- Errington, Timothy M., et al. "Investigating the Replicability of Preclinical Cancer Biology." *eLife* 10 (2021): e71601.

### Clinical Trials

- Unger, Joseph M., et al. "Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation." *Journal of the National Cancer Institute* 111, no. 3 (2019): 245-255.
- Anderson, Martin L., et al. "Compliance with Results Reporting at ClinicalTrials.gov." *New England Journal of Medicine* 372 (2015): 1031-1039.
- Fogel, David B. "Factors Associated with Clinical Trials That Fail and Opportunities for Improving the Likelihood of Success." *Contemporary Clinical Trials Communications* 11 (2018): 156-164.

### Drug Development

- DiMasi, Joseph A., Henry G. Grabowski, and Ronald W. Hansen. "Innovation in the Pharmaceutical Industry: New Estimates of R&D Costs." *Journal of Health Economics* 47 (2016): 20-33.
- Wouters, Olivier J., Martin McKee, and Jeroen Luyten. "Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018." *JAMA* 323, no. 9 (2020): 844-853.
- Scannell, Jack W., et al. "Diagnosing the Decline in Pharmaceutical R&D Efficiency." *Nature Reviews Drug Discovery* 11 (2012): 191-200.

### Workforce

- National Academies. *The Next Generation of Biomedical and Behavioral Sciences Researchers*. 2018.
- Lauer, Michael S., et al. "NIH Peer Review: Criterion Scores Completely Account for Racial Disparities in Overall Impact Scores." *Science Advances* 7, no. 47 (2021): eabj0675.
- Ginther, Donna K., et al. "Race, Ethnicity, and NIH Research Awards." *Science* 333, no. 6045 (2011): 1015-1019.
- Sauermann, Henry, and Michael Roach. "Why Pursue the Postdoc Path?" *Science* 352, no. 6286 (2016): 663-664.

## Books

- Varmus, Harold. *The Art and Politics of Science*. New York: W.W. Norton, 2009.
- Stephan, Paula. *How Economics Shapes Science*. Cambridge: Harvard University Press, 2012.
- Temin, Peter. *The Fall of the Faculty: The Rise of the All-Administrative University and Why It Matters*. Oxford: Oxford University Press, 2011.
- Angell, Marcia. *The Truth About the Drug Companies: How They Deceive Us and What to Do About It*. New York: Random House, 2005.
- Bush, Vannevar. *Science, the Endless Frontier*. Washington: Government Printing Office, 1945. Reprinted NSF, 1960.
- Collins, Francis. *The Language of Life: DNA and the Revolution in Personalized Medicine*. New York: Harper, 2010.

## Organizations

### Research Advocacy and Policy

| Organization | Focus | Website |
|-------------|-------|---------|
| Research!America | Public advocacy for research funding | <https://www.researchamerica.org/> |
| Federation of American Societies for Experimental Biology (FASEB) | Scientific society coalition, policy advocacy | <https://www.faseb.org/> |
| Association of American Medical Colleges (AAMC) | Medical education and research policy | <https://www.aamc.org/> |
| Association of American Universities (AAU) | Research university policy and advocacy | <https://www.aau.edu/> |
| Council on Governmental Relations (COGR) | Federal research administration policy | <https://www.cogr.edu/> |

### Reproducibility and Reform

| Organization | Focus | Website |
|-------------|-------|---------|
| Center for Open Science | Open science, pre-registration, reproducibility | <https://www.cos.io/> |
| METRICS (Stanford) | Meta-research innovation center | <https://metrics.stanford.edu/> |
| Future of Research | Trainee-led advocacy for research reform | <https://www.futureofresearch.org/> |
| Rescuing Biomedical Research | Scientist-led reform coalition | <https://rescuingbiomedicalresearch.org/> |

### Disease Advocacy (Selected)

| Organization | Focus | Website |
|-------------|-------|---------|
| American Cancer Society | Cancer research and patient advocacy | <https://www.cancer.org/> |
| Alzheimer's Association | Alzheimer's research and support | <https://www.alz.org/> |
| American Heart Association | Cardiovascular research and health | <https://www.heart.org/> |
| National Organization for Rare Disorders (NORD) | Rare disease research and access | <https://rarediseases.org/> |
| Cystic Fibrosis Foundation | CF research and drug development | <https://www.cff.org/> |

## Data Sources for Ongoing Monitoring

| Source | What It Tracks | Update Frequency |
|--------|---------------|-----------------|
| NIH Data Book | Funding, success rates, workforce | Annual |
| NIH RePORTER | Individual grants and projects | Continuous |
| ClinicalTrials.gov | Trial registrations and results | Continuous |
| NSF Science and Engineering Indicators | National research statistics | Biennial |
| PhRMA Industry Profile | Industry R&D spending | Annual |
| Retraction Watch | Research retractions and integrity | Continuous |

---

## Document Navigation

- Previous: [Roadmap](08-roadmap.md)
- Next: [Actions](10-actions.md)
